213 related articles for article (PubMed ID: 22787142)
61. Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity.
Agren LC; Ekman L; Löwenadler B; Nedrud JG; Lycke NY
J Immunol; 1999 Feb; 162(4):2432-40. PubMed ID: 9973526
[TBL] [Abstract][Full Text] [Related]
62. Partitioning, diffusion, and ligand binding of raft lipid analogs in model and cellular plasma membranes.
Sezgin E; Levental I; Grzybek M; Schwarzmann G; Mueller V; Honigmann A; Belov VN; Eggeling C; Coskun U; Simons K; Schwille P
Biochim Biophys Acta; 2012 Jul; 1818(7):1777-84. PubMed ID: 22450237
[TBL] [Abstract][Full Text] [Related]
63. The nucleotide exchange factors Grp170 and Sil1 induce cholera toxin release from BiP to enable retrotranslocation.
Williams JM; Inoue T; Chen G; Tsai B
Mol Biol Cell; 2015 Jun; 26(12):2181-9. PubMed ID: 25877869
[TBL] [Abstract][Full Text] [Related]
64. Attenuated endocytosis and toxicity of a mutant cholera toxin with decreased ability to cluster ganglioside GM1 molecules.
Wolf AA; Jobling MG; Saslowsky DE; Kern E; Drake KR; Kenworthy AK; Holmes RK; Lencer WI
Infect Immun; 2008 Apr; 76(4):1476-84. PubMed ID: 18212085
[TBL] [Abstract][Full Text] [Related]
65. Identification of host cell factors required for intoxication through use of modified cholera toxin.
Guimaraes CP; Carette JE; Varadarajan M; Antos J; Popp MW; Spooner E; Brummelkamp TR; Ploegh HL
J Cell Biol; 2011 Nov; 195(5):751-64. PubMed ID: 22123862
[TBL] [Abstract][Full Text] [Related]
66. Entry of protein toxins into mammalian cells by crossing the endoplasmic reticulum membrane: co-opting basic mechanisms of endoplasmic reticulum-associated degradation.
Lord JM; Roberts LM; Lencer WI
Curr Top Microbiol Immunol; 2005; 300():149-68. PubMed ID: 16573240
[TBL] [Abstract][Full Text] [Related]
67. Protein disulfide isomerase-like proteins play opposing roles during retrotranslocation.
Forster ML; Sivick K; Park YN; Arvan P; Lencer WI; Tsai B
J Cell Biol; 2006 Jun; 173(6):853-9. PubMed ID: 16785320
[TBL] [Abstract][Full Text] [Related]
68. Caveolin-1 directly interacts with UT-A1 urea transporter: the role of caveolae/lipid rafts in UT-A1 regulation at the cell membrane.
Feng X; Huang H; Yang Y; Fröhlich O; Klein JD; Sands JM; Chen G
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1514-20. PubMed ID: 19369293
[TBL] [Abstract][Full Text] [Related]
69. The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses.
Bagley K; Xu R; Ota-Setlik A; Egan M; Schwartz J; Fouts T
Hum Vaccin Immunother; 2015; 11(9):2228-40. PubMed ID: 26042527
[TBL] [Abstract][Full Text] [Related]
70. Aminoacyl-tRNA synthetase-interacting multi-functional protein, p43, is imported to endothelial cells via lipid rafts.
Yi JS; Lee JY; Chi SG; Kim JH; Park SG; Kim S; Ko YG
J Cell Biochem; 2005 Dec; 96(6):1286-95. PubMed ID: 16167337
[TBL] [Abstract][Full Text] [Related]
71. A novel concept in mucosal adjuvanticity: the CTA1-DD adjuvant is a B cell-targeted fusion protein that incorporates the enzymatically active cholera toxin A1 subunit.
Agren L; Löwenadler B; Lycke N
Immunol Cell Biol; 1998 Jun; 76(3):280-7. PubMed ID: 9682972
[TBL] [Abstract][Full Text] [Related]
72. CTA1: Purified and display onto gram-positive enhancer matrix (GEM) particles as mucosal adjuvant.
Zhang Y; Yu X; Hou L; Chen J; Li P; Qiao X; Zheng Q; Hou J
Protein Expr Purif; 2018 Jan; 141():19-24. PubMed ID: 28866467
[TBL] [Abstract][Full Text] [Related]
73. Structural basis for the activation of cholera toxin by human ARF6-GTP.
O'Neal CJ; Jobling MG; Holmes RK; Hol WG
Science; 2005 Aug; 309(5737):1093-6. PubMed ID: 16099990
[TBL] [Abstract][Full Text] [Related]
74. The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues.
Eriksson AM; Schön KM; Lycke NY
J Immunol; 2004 Sep; 173(5):3310-9. PubMed ID: 15322194
[TBL] [Abstract][Full Text] [Related]
75. Fusion proteins containing the A2 domain of cholera toxin assemble with B polypeptides of cholera toxin to form immunoreactive and functional holotoxin-like chimeras.
Jobling MG; Holmes RK
Infect Immun; 1992 Nov; 60(11):4915-24. PubMed ID: 1399002
[TBL] [Abstract][Full Text] [Related]
76. Cholesterol at the endoplasmic reticulum: roles of the sigma-1 receptor chaperone and implications thereof in human diseases.
Hayashi T; Su TP
Subcell Biochem; 2010; 51():381-98. PubMed ID: 20213551
[TBL] [Abstract][Full Text] [Related]
77. Cholera toxin binds to lipid rafts but has a limited specificity for ganglioside GM1.
Blank N; Schiller M; Krienke S; Wabnitz G; Ho AD; Lorenz HM
Immunol Cell Biol; 2007 Jul; 85(5):378-82. PubMed ID: 17325693
[TBL] [Abstract][Full Text] [Related]
78. Application of the biotin-labeled toxin mutant for affinity isolation of associated proteins in the mammalian cells.
Yoon JG; Hwang HJ; Cho JA
J Biosci Bioeng; 2018 May; 125(5):497-504. PubMed ID: 29291913
[TBL] [Abstract][Full Text] [Related]
79. FAT/CD36-mediated long-chain fatty acid uptake in adipocytes requires plasma membrane rafts.
Pohl J; Ring A; Korkmaz U; Ehehalt R; Stremmel W
Mol Biol Cell; 2005 Jan; 16(1):24-31. PubMed ID: 15496455
[TBL] [Abstract][Full Text] [Related]
80. Intoxication of zebrafish and mammalian cells by cholera toxin depends on the flotillin/reggie proteins but not Derlin-1 or -2.
Saslowsky DE; Cho JA; Chinnapen H; Massol RH; Chinnapen DJ; Wagner JS; De Luca HE; Kam W; Paw BH; Lencer WI
J Clin Invest; 2010 Dec; 120(12):4399-4409. PubMed ID: 21041954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
